A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expressionShunsuke Meike, Osamu Inanami, Hironobu Yasui et al.|Molecular Cancer|2011Cited by 23